🇺🇸 FDA
Patent

US 6399370

Compositions and methods for use of defensin

expired A61KA61K38/00A61P

Quick answer

US patent 6399370 (Compositions and methods for use of defensin) held by Magainin Pharmaceuticals Inc. expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Magainin Pharmaceuticals Inc.
Grant date
Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61P, A61P11/00, A61P17/00